FA

Faruck Anaimalai Umer

Director Director DIN 08851580
DIN 08851580 First appointment Aug 2020 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2020
Shareholding value Locked Premium profile

About Faruck Anaimalai Umer

Faruck Anaimalai Umer has 5 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 08851580
Primary Designation Director
First Appointment 27 Aug 2020
Oldest Company Age 5 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Clone Biosciences Private Limited U73100TN2020PTC137468
Director 27 Aug 2020 2020 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Clone Biosciences Private Limited
Premium access

Shareholding and investment profile for Faruck Anaimalai Umer

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Faruck Anaimalai Umer

Faruck Anaimalai Umer has 5 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Faruck Anaimalai Umer is associated with 0 companies as Director.

Faruck Anaimalai Umer has expertise in General Business.

Faruck Anaimalai Umer has 5 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available